Literature DB >> 15338269

Innervation of the substantia nigra.

Ulrich Misgeld1.   

Abstract

This review describes inputs to neurons in the substantia nigra and contrasts them with the action of agonists for the putative receptors through which they act. Special emphasis is placed on gamma-aminobutyric acid (GABA) afferents. Dopamine released from the somato-dendritic compartment of dopamine neurons and endocannabinoids released from dopamine and GABA neurons serve as retrograde signals to modulate GABA release. The release may be fostered by Ca(2+) release from intracellular Ca(2+) stores, which in turn may be influenced by the inputs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15338269     DOI: 10.1007/s00441-004-0918-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  16 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Intrinsic and integrative properties of substantia nigra pars reticulata neurons.

Authors:  F-M Zhou; C R Lee
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

Review 3.  A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease.

Authors:  Giulia Ambrosi; Silvia Cerri; Fabio Blandini
Journal:  J Neural Transm (Vienna)       Date:  2014-01-01       Impact factor: 3.575

4.  Presynaptic GABAB autoreceptor regulation of nicotinic acetylcholine receptor mediated [(3)H]-GABA release from mouse synaptosomes.

Authors:  Tristan D McClure-Begley; Sharon R Grady; Michael J Marks; Allan C Collins; Jerry A Stitzel
Journal:  Biochem Pharmacol       Date:  2014-06-19       Impact factor: 5.858

Review 5.  Kynurenines in Parkinson's disease: therapeutic perspectives.

Authors:  Dénes Zádori; Péter Klivényi; József Toldi; Ferenc Fülöp; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-08-20       Impact factor: 3.575

6.  An ultra-short dopamine pathway regulates basal ganglia output.

Authors:  Fu-Wen Zhou; Ying Jin; Shannon G Matta; Ming Xu; Fu-Ming Zhou
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

Review 7.  Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies.

Authors:  D Zádori; P Klivényi; E Vámos; F Fülöp; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2009-07-18       Impact factor: 3.575

8.  Age- and gender-related differences in GABAA receptor-mediated postsynaptic currents in GABAergic neurons of the substantia nigra reticulata in the rat.

Authors:  O Chudomel; H Herman; K Nair; S L Moshé; A S Galanopoulou
Journal:  Neuroscience       Date:  2009-06-13       Impact factor: 3.590

9.  GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo.

Authors:  Elena Brazhnik; Fulva Shah; James M Tepper
Journal:  J Neurosci       Date:  2008-10-08       Impact factor: 6.167

Review 10.  Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.

Authors:  Dénes Zádori; Levente Szalárdy; József Toldi; Ferenc Fülöp; Péter Klivényi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2012-11-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.